Dynocardia, Inc.

Dynocardia develops ViTrack, a cuff-less, wrist-wearable device that continuously measures beat-to-beat blood pressure using optomechanical sensors and computer vision technology for hospital and clinical monitoring. The company is advancing its technology toward FDA 510(k) clearance to enable continuous blood pressure monitoring for critically ill patients in hospital settings.